DNA 0.00% 2.9¢ donaco international limited

Ann: March Quarter 2019 Trading Update, page-3

  1. 7,343 Posts.
    lightbulb Created with Sketch. 2103
    I wouldn't say excellent, but it's a comfort that operations are not going backwards anymore. Based on that EBITDA my guess is that's a run rate of about 22m NPAT per year. Remember, that's about 45% of the FY17 underlying result (excluding vendor payment) of about A50m NPAT. A very long way to go, however it looks like we are going to avoid yet another write down.

    In terms of the review, I thought the arbitration was holding that up, but no, it's 'shareholder matters'.

    Last edited by JoeGambler: 26/04/19
 
watchlist Created with Sketch. Add DNA (ASX) to my watchlist
(20min delay)
Last
2.9¢
Change
0.000(0.00%)
Mkt cap ! $35.82M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
2 178878 2.9¢
 

Sellers (Offers)

Price($) Vol. No.
3.2¢ 30333 1
View Market Depth
Last trade - 16.16pm 13/09/2024 (20 minute delay) ?
DNA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.